AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
FLOW trial and GLP-1 cost rant
Docs Who Lift
Intro
The hosts explore the FLOW trial's findings on the renal outcomes of a medication for patients with type 2 diabetes and obesity, emphasizing the increased risks of kidney and heart disease in these populations. They stress the importance of focusing on heart and kidney health in managing complications and using kidney protective medications to prevent adverse events in diabetic patients.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode